1. Viral Replicon Systems and Their Biosafety Aspects
   Karen van der Meulen et al, 2023, Applied Biosafety CrossRef
2. Replicating viral vector platform exploits alarmin signals for potent CD8+ T cell-mediated tumour immunotherapy
   Sandra M. Kallert et al, 2017, Nature Communications CrossRef